OHSU in the news

Teprotumumab confers long-term benefits in thyroid eye disease

Healio Endocrinology October 23, 2020
A report on the clinical trial results of monoclonal antibody teprotumumab, now FDA-approved to treat thyroid eye disease. Roger Dailey M.D., says: “these data indicate that all patients completing the long-term evaluation had at least some improvement in one or more of the major outcomes under analysis.”

Coronavirus update: U.S. death toll tops 223,000; rural hospitals are filling and the Dakotas lead the nation by new infections

MarketWatch October 23, 2020
Esther Choo, M.D., M.P.H., speaks with MarketWatch regarding the importance of COVID-19 health care access in rural settings. She says: “Sometimespeople drive in from rural areas three hours away; it’s such a big deal for them to get in. And if they’re getting sicker, the last thing they can do is hop in a car and drive themselves back and they don’t have a family member who can bring them back.”

OHSU Doernbecher Children's Hospital: Brayden's Story

KATU-TV October 21, 2020
A KATU-TV campaign sponsored by Credit Unions for Kids helps fundraise for the Rood Family Pavilion. Dana Brander, M.D., Cindy McEvoy, M.D. and Carrie Phillipi, M.D., Ph.D., as well as patient Brayden, are featured.

OHSU Doernbecher Children's Hospital: Noah's Story

KATU-TV October 21, 2020
A KATU-TV campaign sponsored by Credit Unions for Kids helps fundraise for the Rood Family Pavilion. Dana Brander, M.D., Cindy McEvoy, M.D. and Carrie Phillipi, M.D., Ph.D., as well as patient Noah are featured.

OHSU Doernbecher Children's Hospital: Chloe's Story

KATU-TV October 21, 2020
A KATU-TV campaign sponsored by Credit Unions for Kids helps fundraise for the Rood Family Pavilion. Dana Brander, M.D., Cindy McEvoy, M.D. and Carrie Phillipi, M.D., Ph.D., as well as patient Chloe are featured.
See more stories